{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:59:07Z","timestamp":1788325147689,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Koch-Institut"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n<jats:title>Hintergrund<\/jats:title>\n<jats:p>Datengrundlagen f\u00fcr systematische, fortlaufende Analysen zur H\u00e4ufigkeit mikrovaskul\u00e4rer Komplikationen von Diabetes mellitus in Deutschland sind bislang nur begrenzt vorhanden. Erstmals wurde gepr\u00fcft, ob Versichertendaten aller gesetzlichen Krankenversicherungen (GKV) nach Datentransparenzverordnung hierf\u00fcr geeignet sind.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methode<\/jats:title>\n<jats:p>Analysiert wurden die GKV-Versichertendaten der Berichtsjahre 2012 und 2013. Die Bezugspopulation wurde identifiziert: Versicherte mit Diabetes, definiert als Dokumentation mindestens zweier ambulanter oder einer station\u00e4ren Diabetesdiagnose gem\u00e4\u00df der Internationalen Klassifikation der Krankheiten (ICD-Codes E10\u2013E14). Komplikationen wurden anhand folgender ICD-Codes definiert: Nephropathie (N08.3), Retinopathie (H36.0), Polyneuropathie (G63.2), diabetisches Fu\u00dfsyndrom (DFS; E10-14.74, E10-14.75), chronische Niereninsuffizienz (N18.-) und Dialysebehandlung (Z49.1, Z49.2, Z99.2). Die Ergebnisse wurden mit Pr\u00e4valenzsch\u00e4tzungen aus Routine- und Registerdaten in Deutschland und im Ausland verglichen.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Ergebnisse<\/jats:title>\n<jats:p>Im Jahr 2013 wurde f\u00fcr 6,6\u202fMio. GKV-Versicherte ein Diabetes dokumentiert (2012: 6,5\u202fMio.). Die chronische Niereninsuffizienz stellte die h\u00e4ufigste Komplikation im Jahr 2013 dar (15,0\u202f%), gefolgt von diabetischer Polyneuropathie (13,5\u202f%), Nephropathie (7,6\u202f%), Retinopathie (7,0\u202f%), DFS (6,1\u202f%) und Dialysebehandlung (0,56\u202f%). W\u00e4hrend Ergebnisse zu diabetischer Retinopathie, Nephropathie und Polyneuropathie im Vergleich zu anderen Pr\u00e4valenzsch\u00e4tzungen f\u00fcr Personen mit Typ-2-Diabetes niedriger ausfielen, sind diese zu Niereninsuffizienz, Dialysebehandlung und DFS vergleichbar.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Schlussfolgerung<\/jats:title>\n<jats:p>Verstetigte Analysen der GKV-Daten sind von hohem Wert f\u00fcr die Diabetes-Surveillance, erfordern jedoch vertiefende Analysen zur \u00dcberpr\u00fcfung und Vereinheitlichung von Falldefinitionen und Dokumentationsverhalten.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00103-020-03211-x","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T13:03:48Z","timestamp":1599051828000},"page":"1219-1230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Einsch\u00e4tzungen zur Pr\u00e4valenz mikrovaskul\u00e4rer Folgeerkrankungen bei Diabetes mellitus in Deutschland. Analyse von Versichertendaten aller gesetzlichen Krankenkassen f\u00fcr die Jahre 2012 und 2013","Estimating prevalent microvascular complications of diabetes mellitus in Germany. Analysis of statutory health insurance data in 2012 and 2013"],"prefix":"10.1007","volume":"63","author":[{"given":"Lukas","family":"Reitzle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Icks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ziese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Scheidt-Nave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"3211_CR1","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/dme.13008","volume":"33","author":"C Heidemann","year":"2016","unstructured":"Heidemann\u00a0C, Du\u00a0Y, Paprott\u00a0R, Haftenberger\u00a0M, Rathmann\u00a0W, Scheidt-Nave\u00a0C (2016) Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German health interview and examination surveys in 1997\u20131999 and 2008\u20132011. Diabet Med 33:1406\u20131414","journal-title":"Diabet Med"},{"key":"3211_CR2","doi-asserted-by":"publisher","DOI":"10.20364\/VA-17.03","volume-title":"Administrative Pr\u00e4valenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015","author":"B Goffrier","year":"2017","unstructured":"Goffrier\u00a0B, Schulz\u00a0M, B\u00e4tzing-Feigenbaum\u00a0J (2017) Administrative Pr\u00e4valenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland (Zi), Berlin https:\/\/doi.org\/10.20364\/VA-17.03 (Versorgungsatlas-Bericht Nr.\u00a017\/03)"},{"key":"3211_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00103-019-03068-9","volume":"63","author":"C Schmidt","year":"2019","unstructured":"Schmidt\u00a0C, Reitzle\u00a0L, Dre\u00df\u00a0J, Rommel\u00a0A, Ziese\u00a0T, Heidemann\u00a0C (2019) Pr\u00e4valenz und Inzidenz des dokumentierten Diabetes mellitus \u2013 Referenzauswertung f\u00fcr die Diabetes-Surveillance auf Basis von Daten aller gesetzlich Krankenversicherten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63:93\u2013102","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3211_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/dme.13902","volume":"36","author":"T Tonnies","year":"2019","unstructured":"Tonnies\u00a0T, Rockl\u00a0S, Hoyer\u00a0A et\u00a0al (2019) Projected number of people with diagnosed Type 2 diabetes in Germany in 2040. Diabet Med 36:1217\u20131225","journal-title":"Diabet Med"},{"key":"3211_CR5","first-page":"629","volume":"111","author":"D Plass","year":"2014","unstructured":"Plass\u00a0D, Vos\u00a0T, Hornberg\u00a0C, Scheidt-Nave\u00a0C, Zeeb\u00a0H, Kramer\u00a0A (2014) Trends in disease burden in Germany: results, implications and limitations of the global burden of disease study. Dtsch Arztebl Int 111:629\u2013638","journal-title":"Dtsch Arztebl Int"},{"key":"3211_CR6","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Emerging Risk Factors Collaboration, Sarwar\u00a0N, Gao\u00a0P et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a\u00a0collaborative meta-analysis of 102 prospective studies. Lancet 375:2215\u20132222","journal-title":"Lancet"},{"key":"3211_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","volume":"26","author":"MJ Fowler","year":"2008","unstructured":"Fowler\u00a0MJ (2008) Microvascular and macrovascular complications of diabetes. Clin Diabetes 26:77\u201382","journal-title":"Clin Diabetes"},{"key":"3211_CR8","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas\u00a0MC, Brownlee\u00a0M, Susztak\u00a0K et\u00a0al (2015) Diabetic kidney disease. Nat Rev Dis Primers 1:15018","journal-title":"Nat Rev Dis Primers"},{"key":"3211_CR9","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong\u00a0TY, Cheung\u00a0CM, Larsen\u00a0M, Sharma\u00a0S, Simo\u00a0R (2016) Diabetic retinopathy. Nat Rev Dis Primers 2:16012","journal-title":"Nat Rev Dis Primers"},{"key":"3211_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman\u00a0EL, Callaghan\u00a0BC, Pop-Busui\u00a0R et al (2019) Diabetic neuropathy. Nat Rev Dis Primers 5:41","journal-title":"Nat Rev Dis Primers"},{"key":"3211_CR11","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi\u00a0M, Rosengren\u00a0A, Svensson\u00a0AM et\u00a0al (2015) Excess mortality among persons with type 2 diabetes. N\u00a0Engl J Med 373:1720\u20131732","journal-title":"N Engl J Med"},{"key":"3211_CR12","unstructured":"Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in der Bundesrepublik Deutschland (Zi) (2019) DMP-Atlas Nordrhein-Westfalen: Regionalisierte Darstellung der Disease-Management-Programme. https:\/\/www.zi-dmp.de\/dmp-atlas_nrw\/. Zugegriffen: 17. Nov. 2019"},{"key":"3211_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00103-012-1650-9","volume":"56","author":"P Kamtsiuris","year":"2013","unstructured":"Kamtsiuris\u00a0P, Lange\u00a0M, Hoffmann\u00a0R et\u00a0al (2013) Die erste Welle der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:620\u2013630","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3211_CR14","doi-asserted-by":"publisher","first-page":"e000135","DOI":"10.1136\/bmjdrc-2015-000135","volume":"3","author":"Y Du","year":"2015","unstructured":"Du\u00a0Y, Heidemann\u00a0C, Schaffrath Rosario\u00a0A et\u00a0al (2015) Changes in diabetes care indicators: findings from German national health interview and examination surveys 1997\u20131999 and 2008\u20132011. BMJ Open Diabetes Res Care 3:e135","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3211_CR15","first-page":"31","volume":"4","author":"J Rosenbauer","year":"2019","unstructured":"Rosenbauer\u00a0J, Neu\u00a0A, Rothe\u00a0U, Seufert\u00a0J, Holl\u00a0RW (2019) Diabetestypen sind nicht auf Altersgruppen beschr\u00e4nkt: Typ-1-Diabetes bei Erwachsenen und Typ-2-Diabetes bei Kindern und Jugendlichen. J\u00a0Health Monit 4:31\u201353","journal-title":"J Health Monit"},{"key":"3211_CR16","first-page":"3","volume":"3","author":"L Gabrys","year":"2018","unstructured":"Gabrys\u00a0L, Heidemann\u00a0C, Schmidt\u00a0C et al (2018) Diabetes-Surveillance in Deutschland \u2013 Auswahl und Definition von Indikatoren. J\u00a0Health Monit 3:3\u201322","journal-title":"J Health Monit"},{"key":"3211_CR17","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (DIMDI) (2019) Informationssystem Versorgungsdaten (Datentransparenz): Datensatzbeschreibung, Version 02.15.000. https:\/\/www.dimdi.de\/static\/.downloads\/deutsch\/versorgungsdaten-datensatzbeschreibung.pdf. Zugegriffen: 16. Mai 2019"},{"key":"3211_CR18","unstructured":"Bundesministerium f\u00fcr Gesundheit (2012) Mitgliederstatistik KM6 2012. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/Statistiken\/GKV\/Mitglieder_Versicherte\/KM6_2012_121120.xls. Zugegriffen: 16. Mai 2019"},{"key":"3211_CR19","unstructured":"Bundesministerium f\u00fcr Gesundheit (2013) Mitgliederstatistik KM6 2013. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/Statistiken\/GKV\/Mitglieder_Versicherte\/KM6_2013-Versicherte.xls. Zugegriffen: 16. Mai 2019"},{"key":"3211_CR20","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (DIMDI) (2019) ICD-10-GM Version 2019. https:\/\/www.dimdi.de\/static\/de\/klassifikationen\/icd\/icd-10-gm\/kode-suche\/htmlgm2019\/. Zugegriffen: 1. Nov. 2019"},{"key":"3211_CR21","first-page":"177","volume":"113","author":"T Tamayo","year":"2016","unstructured":"Tamayo\u00a0T, Brinks\u00a0R, Hoyer\u00a0A, Ku\u00df\u00a0O, Rathmann\u00a0W (2016) The prevalence and incidence of diabetes in Germany: an analysis of statutory health insurance data on 65 million individuals from the years 2009 and 2010. Dtsch Arztebl Int 113:177","journal-title":"Dtsch Arztebl Int"},{"key":"3211_CR22","first-page":"54","volume":"4","author":"C Schmidt","year":"2019","unstructured":"Schmidt\u00a0C, Heidemann\u00a0C, Rommel\u00a0A et al (2019) Sekund\u00e4rdaten in der Diabetes-Surveillance \u2013 Kooperationsprojekte und Referenzdefinition zur dokumentierten Diabetespr\u00e4valenz. J\u00a0Health Monit 4:54\u201369","journal-title":"J Health Monit"},{"key":"3211_CR23","unstructured":"Institut f\u00fcr das Entgeltsystem im Krankenhaus (InEK GmbH) (2018) Deutsche Kodierrichtlinien Version 2019. https:\/\/www.g-drg.de\/G-DRG-System_2019\/Kodierrichtlinien\/Deutsche_Kodierrichtlinien_2019. Zugegriffen: 16. Mai 2019"},{"key":"3211_CR24","first-page":"70","volume":"4","author":"L Reitzle","year":"2019","unstructured":"Reitzle\u00a0L, Schmidt\u00a0C, Scheidt-Nave\u00a0C, Ziese\u00a0T (2019) Studie zur Gesundheitsberichterstattung \u00fcber nicht\u00fcbertragbare Erkrankungen am Beispiel von Diabetes mellitus im internationalen Vergleich. J\u00a0Health Monit 4:70\u201392","journal-title":"J Health Monit"},{"key":"3211_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau\u00a0JW, Rogers\u00a0SL, Kawasaki\u00a0R et\u00a0al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556\u2013564","journal-title":"Diabetes Care"},{"key":"3211_CR26","unstructured":"Swedish National Diabetes Register (NDR) (2019) Ett knapptryck f\u00f6r f\u00f6rb\u00e4ttringsarbete. https:\/\/www.ndr.nu\/#\/knappen. Zugegriffen: 12. Juli 2019"},{"key":"3211_CR27","unstructured":"Gesundheitsberichterstattung des Bundes (2019) Behandlungsverfahren bei Dialysepatientinnen und -patienten (Anzahl). Bestand an Dialysepatientinnen und -patienten. Gliederungsmerkmale: Jahre, Region. http:\/\/www.gbe-bund.de\/. Zugegriffen: 20. Mai 2019"},{"key":"3211_CR28","unstructured":"German DOPPS Practice Monitor (2016) Diabetes at study entry. https:\/\/www.dopps.org\/DPM\/Germany\/. Zugegriffen: 16. Juni 2019"},{"key":"3211_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ki.2013.143","volume":"84","author":"W Kleophas","year":"2013","unstructured":"Kleophas\u00a0W, Karaboyas\u00a0A, Li\u00a0Y et\u00a0al (2013) Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs. Kidney Int 84:578\u2013584","journal-title":"Kidney Int"},{"key":"3211_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12882-015-0177-3","volume":"16","author":"E Weisshaar","year":"2015","unstructured":"Weisshaar\u00a0E, Weiss\u00a0M, Passlick-Deetjen\u00a0J, Tschulena\u00a0U, Maleki\u00a0K, Mettang\u00a0T (2015) Laboratory and dialysis characteristics in hemodialysis patients suffering from chronic itch\u2014results from a\u00a0representative cross-sectional study. BMC Nephrol 16:184","journal-title":"BMC Nephrol"},{"key":"3211_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","volume":"49","author":"P Zhang","year":"2017","unstructured":"Zhang\u00a0P, Lu\u00a0J, Jing\u00a0Y, Tang\u00a0S, Zhu\u00a0D, Bi\u00a0Y (2017) Global epidemiology of diabetic foot ulceration: a\u00a0systematic review and meta-analysis (dagger). Ann Med 49:106\u2013116","journal-title":"Ann Med"},{"key":"3211_CR32","unstructured":"GKV-Spitzenverband (2011) Rahmenempfehlungen \u2013 Podologische Therapie \u2013 nach \u00a7 125 Abs. 1 SGB V, Anlage 3. https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/ambulante_leistungen\/heilmittel\/heilmittel_rahmenempfehlungen\/heilmittel_podologen\/HeilM_Empf_Podologen_Anlage_3_2011.pdf. Zugegriffen: 1. Nov. 2019"},{"key":"3211_CR33","volume-title":"Routinedaten im Gesundheitswesen: Handbuch Sekund\u00e4rdatenanalyse: Grundlagen, Methoden und Perspektiven","author":"E Swart","year":"2014","unstructured":"Swart\u00a0E, Ihle\u00a0P, Gothe\u00a0H, Matusiewicz\u00a0D (2014) Routinedaten im Gesundheitswesen: Handbuch Sekund\u00e4rdatenanalyse: Grundlagen, Methoden und Perspektiven, 2.\u00a0Aufl. Huber, Bern","edition":"2"},{"key":"3211_CR34","first-page":"131","volume-title":"Versorgungs-Report 2013\/2014 : Schwerpunkt: Depression. Stuttgart","author":"N M\u00fcller","year":"2014","unstructured":"M\u00fcller\u00a0N, Heller\u00a0T, Freitag\u00a0M, Gerste\u00a0B, Haupt\u00a0C, M\u00fcller\u00a0UA (2014) Diabetes mellitus Typ 2. In: Klauber\u00a0J, G\u00fcnster\u00a0C, Gerste\u00a0B, Robra\u00a0BP, Schmake\u00a0N (Hrsg) Versorgungs-Report 2013\/2014 : Schwerpunkt: Depression. Stuttgart. Schattauer, Deutschland, S 131\u2013154"},{"key":"3211_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1055\/s-0034-1375675","volume":"122","author":"I Koster","year":"2014","unstructured":"Koster\u00a0I, Huppertz\u00a0E, Hauner\u00a0H, Schubert\u00a0I (2014) Costs of diabetes mellitus (coDiM) in Germany, direct per-capita costs of managing hyperglycaemia and diabetes complications in 2010 compared to 2001. Exp Clin Endocrinol Diabetes 122:510\u2013516","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3211_CR36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12889-015-2188-1","volume":"15","author":"MW Boehme","year":"2015","unstructured":"Boehme\u00a0MW, Buechele\u00a0G, Frankenhauser-Mannuss\u00a0J et al (2015) Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in south western Germany\u2014a retrospective cohort and case control study in claims data of a\u00a0large statutory health insurance. BMC Public Health 15:855","journal-title":"BMC Public Health"},{"key":"3211_CR37","volume-title":"Versorgungsreport Diabetes mellitus","author":"B Deckenbach","year":"2018","unstructured":"Deckenbach\u00a0B, Nolting\u00a0H\u2011D, Tisch\u00a0T, Zich\u00a0K (2018) Versorgungsreport Diabetes mellitus, 1.\u00a0Aufl. medhochzwei, Heidelberg","edition":"1"},{"key":"3211_CR38","unstructured":"Hagen B, Altenhofen L, Groos S, Kretschmann J, Weber A (2012) Qualit\u00e4tssicherungsbericht 2012 Disease-Management-Programme in Nordrhein. https:\/\/www.kvno.de\/downloads\/quali\/qualbe_dmp12.pdf. Zugegriffen: 16. Mai 2019"},{"key":"3211_CR39","unstructured":"Hagen B, Altenhofen L, Groos S, Kretschmann J, Weber A (2013) Qualit\u00e4tssicherungsbericht 2013 Disease-Management-Programme in Nordrhein. https:\/\/www.kvno.de\/downloads\/quali\/qualbe_dmp13.pdf. Zugegriffen: 16. Mai 2019"},{"key":"3211_CR40","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00125-011-2198-1","volume":"54","author":"HP Hammes","year":"2011","unstructured":"Hammes\u00a0HP, Kerner\u00a0W, Hofer\u00a0S et\u00a0al (2011) Diabetic retinopathy in type 1 diabetes\u2014a contemporary analysis of 8,784 patients. Diabetologia 54:1977\u20131984","journal-title":"Diabetologia"},{"key":"3211_CR41","doi-asserted-by":"publisher","first-page":"e0132492","DOI":"10.1371\/journal.pone.0132492","volume":"10","author":"HP Hammes","year":"2015","unstructured":"Hammes\u00a0HP, Welp\u00a0R, Kempe\u00a0HP et al (2015) Risk factors for retinopathy and DME in type 2 diabetes-results from the German\/Austrian DPV database. PLoS ONE 10:e132492","journal-title":"PLoS ONE"},{"key":"3211_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-019-0837-x","volume":"18","author":"P Bramlage","year":"2019","unstructured":"Bramlage\u00a0P, Lanzinger\u00a0S, van Mark\u00a0G et al (2019) Patient and disease characteristics of type\u20112 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovasc Diabetol 18:33","journal-title":"Cardiovasc Diabetol"},{"key":"3211_CR43","doi-asserted-by":"publisher","first-page":"e3020","DOI":"10.1002\/dmrr.3020","volume":"34","author":"B Bohn","year":"2018","unstructured":"Bohn\u00a0B, Grunerbel\u00a0A, Altmeier\u00a0M et\u00a0al (2018) Diabetic foot syndrome in patients with diabetes. A multicenter German\/Austrian DPV analysis on 33 870 patients. Diabetes Metab Res Rev 34:e3020","journal-title":"Diabetes Metab Res Rev"},{"key":"3211_CR44","unstructured":"Scottish Diabetes Data Group (2018) Scottish diabetes survey 2017. https:\/\/www.diabetesinscotland.org.uk\/publications\/#survey-docs. Zugegriffen: 12. Juli 2019"},{"key":"3211_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/bjophthalmol-2013-304017","volume":"99","author":"RL Thomas","year":"2015","unstructured":"Thomas\u00a0RL, Dunstan\u00a0FD, Luzio\u00a0SD et\u00a0al (2015) Prevalence of diabetic retinopathy within a\u00a0national diabetic retinopathy screening service. Br J Ophthalmol 99:64\u201368","journal-title":"Br J Ophthalmol"},{"key":"3211_CR46","unstructured":"Centers for Disease Control and Prevention (2019) Vision & eye health surveillance system (VEHSS). Percentage of people with diabetic retinopathy, based on examination. https:\/\/www.cdc.gov\/visionhealth\/vehss\/project\/index.html. Zugegriffen: 12. Juli 2019"},{"key":"3211_CR47","unstructured":"NHS Digital (2017) National diabetes audit, 2015\u201316\u2014report 2a: complications and mortality (complications of diabetes). https:\/\/files.digital.nhs.uk\/pdf\/4\/t\/national_diabetes_audit__2015-16__report_2a.pdf. Zugegriffen: 12. Juli 2019"},{"key":"3211_CR48","unstructured":"Centers for Disease Control and Prevention (2019) Chronic kidney disease surveillance system\u2014United States. CKD prevalence by diabetes mellitus status. http:\/\/www.cdc.gov\/ckd. Zugegriffen: 12. Juli 2019"},{"key":"3211_CR49","unstructured":"Kassen\u00e4rztliche Vereinigung Nordrhein (2019) Praxismanual \u2013 Eine Arbeitshilfe f\u00fcr die strukturierten Behandlungsprogramme. https:\/\/www.kvno.de\/downloads\/vertraege\/dmp\/Praxismanual_DMP_Nordrhein.pdf. Zugegriffen: 16. Mai 2019"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-020-03211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-020-03211-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-020-03211-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:23:22Z","timestamp":1630538602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-020-03211-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3211"],"URL":"https:\/\/doi.org\/10.1007\/s00103-020-03211-x","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"2 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Reitzle, C.\u00a0Schmidt, Y.\u00a0Du, A.\u00a0Icks, B.\u00a0Hagen, T.\u00a0Ziese und C.\u00a0Scheidt-Nave geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}